神経学におけるAIの世界市場

Report Highlights

The global market for AI in neurology was valued at $563.6 million in 2024 and is estimated to increase from $705.6 million in 2025 to reach $2.5 billion by 2030, at a compound annual growth rate (CAGR) of 28.9% from 2025 through 2030.

Report Includes

• 52 data tables and 69 additional tables
• An overview of the global market for AI in neurology
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, and projected CAGRs through 2030
• Evaluation of the current market size and revenue growth prospects specific to AI in neurology, accompanied by a market share analysis by product type, application, end-user industry and region
• Analysis of current and future demand in the global neurology market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges and opportunities affecting market growth
• Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
• Market share analysis of the key market participants in the neurology market, along with their research priorities, product portfolios, global rankings and competitive landscape
• Company profiles of major players within the industry, including Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Nvidia Corp., and Canon Inc.

Report Scope

The report provides an overview of the global market for AI in neurology and analyzes market trends. It includes global revenue (in $ millions) with 2024 as the base year, estimated data for 2025, and projections from 2026 to 2030. The market is segmented based on type, end-user industry and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America, focusing on major countries in these regions.

The report provides an in-depth analysis of the global AI in neurology market, emphasizing the major driving forces and emerging technologies shaping this evolving field. It explores how artificial intelligence (AI) transforms neurology through enhanced diagnostic capabilities, early disease detection, personalized treatment planning and remote patient monitoring for neurological conditions such as Alzheimer’s, Parkinson’s, stroke and epilepsy.

This report analyzes AI adoption and use cases in neurology, highlighting geographic trends across North America, Europe, Asia-Pacific, South America and MEA. It also examines AI disruption across industry verticals and value chain stages, while presenting market spending patterns, investment forecasts, major company expenditures and venture capital funding in AI-driven neurology technologies.

The report examines the environmental, social and corporate governance (ESG) aspects influencing the adoption and ethical use of AI in neurology, reviews recent patent filings and innovation trends that reflect technological advancements in AI-based neuroimaging, brain-computer interfaces, digital therapeutics and wearable neurological devices.

A comprehensive competitive landscape analysis ranks and evaluates the market share of major players globally, highlighting their strategic initiatives, R&D investments and technological strengths in AI neurology solutions. The report concludes with detailed company profiles of key market participants, offering insights into their product portfolios, partnerships, acquisitions and contributions to the advancement of AI in neurological healthcare.

Table of Contents

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
AI-Driven Personalization in Neurology: Advancing Prognosis, Treatment and Outcomes
Porter’s Five Forces Analysis
Competitive Rivalry (High)
Threat of New Entrants (Moderate to High)
Bargaining Power of Suppliers (Moderate)
Bargaining Power of Buyers (Moderate)
Threat of Substitutes (Low to Moderate)
Conclusion
Macro-Economic Factor Analysis
Economic Growth and Healthcare Spending
Technological Advancement and R&D Investment
Regulatory Environment and Policy Support
Demographic Trends and Disease Burden
Labor Market and Talent Availability
Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Prevalence of Neurological Disorders
Demand for Early Diagnosis and Precision Medicine
Advancements in Neuroimaging and Data Analytics
Support from Governments and Regulatory Agencies
Market Restraints
Neurological Workforce Paucity in Rural Areas and LMICs
High Cost of AI Integration
Market Opportunities
Future Opportunities for AI in Neurology: Revolutionizing Diagnostics
AI in Personalized Neurological Treatment Plans
Market Challenges
Lack of Standardized Validation and Transparency in AI-Based Neurology Tools
Data Fragmentation Across Neurological Care Systems
Chapter 4 Regulatory Landscape
Regulatory Scenario
Regulatory Landscape in the U.S. for AI in Neurology: Devices
Regulatory Landscape in the U.S. for AI in Neurology: AI/ML tools in Drugs and Biologics
Regulatory Landscape in Europe for AI in Neurology
Regulatory Landscape in Japan for AI in Neurology
Regulatory Landscape in India for AI in Neurology
Chapter 5 Emerging Technologies and Patent Analysis
Key Takeaways
Generative AI in Neurology: Advancing Clinical Support and Knowledge Performance
AI for Nuclear Neuroimaging in Neurology
Integrating AI-Enhanced Brain-Computer Interfaces with Traditional and Complementary Neurology
AI Tools for Cognitive and Mental Health in Neurology
Emerging Role of LLMs and NLP in Neurology AI Applications
Emerging Trends in AI for Neurology
Patent Analysis
Key Findings
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Breakdown by Product Type
Key Takeaways
AI in Neuro-Oncology and Neuroinflammatory Disorders
AI in Neurovascular and Traumatic Brain Injury
AI in Epilepsy and Functional Brain Disorders
AI in Spinal and Movement Disorders
AI in Neurodevelopmental and Psychiatric Conditions
Market Breakdown by Application
Key Takeaways
Neuro Imaging Analysis
Electroencephalography (EEG) Interpretation
Clinical Decision Support
Drug Discovery and Development
Others
Market Breakdown by Technology
Key Takeaways
Machine Learning and Deep Learning
Natural Language Processing (NLP)
Others
Market Breakdown, by End User
Key Takeaways
Hospitals and Clinics
Diagnostics Centers
Research and Development Centers
Geographic Breakdown
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Company Share Analysis
Key Developments and Strategies
Partnerships and Collaborations
Acquisition
Business Expansions
Product Launches, Approval
Chapter 8 Environmental, Social and Governance (ESG) Perspective
Introduction to ESG
The Role of AI in Neurology for Advancing Sustainability and Investment Impact
ESG Sustainability in AI for Neurology: Efforts, by Major Players
ESG Risk Ratings
Concluding Remarks from BCC
Chapter 9 Appendix
Research Methodology
References
Abbreviations
Company Profiles
ACTIV SURGICAL
AIRAMED GMBH
BRAINOMIX
BRAINQ TECHNOLOGIES LTD.
CANON INC.
GE HEALTHCARE
KONINKLIJKE PHILIPS N.V.
MEDTRONIC
NEOSOMA INC.
NEURALINK
NEUROX
NVIDIA CORP.
QURE.AI
SIEMENS HEALTHINEERS AG
VIZ.AI INC.
Few Emerging Start-ups/Market Disruptors

List of Tables

List of Tables
Summary Table : Global Market for AI in Neurology, by Region, Through 2030
Table 1 : Benefits of Artificial Intelligence (AI) in Neurology
Table 2 : The Neurologist’s AI Armamentarium
Table 3 : FDA Cleared Some Neuroimaging AI Products
Table 4 : Porter’s Five Forces: Rating Scale
Table 5 : Ten Neurological Conditions that Accounted for the Greatest DALYs in 2021
Table 6 : FDA Cleared AI Algorithms, by Specialty, as of May 30, 2025
Table 7 : Progressive Reduction of General Neurologists, 2014–2023
Table 8 : Comparison Between Traditional Accuracy and AI-Based Accuracy
Table 9 : AI‐Driven Precision Neurological Care: Emerging Tasks and Tool Descriptions
Table 10 : Emerging Applications of AI Techniques in the Neurological Sciences
Table 11 : Select Published Patents on AI in Neurology, January 2025–July 2025
Table 12 : Global Market for AI in Neurology, by Product Type, Through 2030
Table 13 : CE Marked Deep Learning Algorithms in Neuroinflammatory Diseases
Table 14 : Global Market for AI in Neuro-Oncology and Neuroinflammatory Disorders, by Region, Through 2030
Table 15 : Global Market for AI in Neurovascular and Traumatic Brain Injury, by Region, Through 2030
Table 16 : Global Market for AI in Epilepsy and Functional Brain Disorders, by Region, Through 2030
Table 17 : Global Market for AI in Spinal and Movement Disorders, by Region, Through 2030
Table 18 : Global Market for AI in Neurodevelopmental and Psychiatric Conditions, by Region, Through 2030
Table 19 : Global Market for AI in Neurology, by Application, Through 2030
Table 20 : Global Market for AI in Neuroimaging Analysis, by Region, Through 2030
Table 21 : Global Market for AI in Electroencephalography (EEG) Interpretation, by Region, Through 2030
Table 22 : Global Market for AI in Clinical Decision Support, by Region, Through 2030
Table 23 : AI-Enabled Drugs Entering the Clinical Phase
Table 24 : Global Market for AI in Drug Discovery and Development, by Region, Through 2030
Table 25 : Global Market for AI in Other Applications, by Region, Through 2030
Table 26 : Global Market for AI in Neurology, by Technology, Through 2030
Table 27 : Global Market for ML/DL in Neurology, by Region, Through 2030
Table 28 : Global Market for NLP in Neurology, by Region, Through 2030
Table 29 : Global Market for Other AI-Based Technologies in Neurology, by Region, Through 2030
Table 30 : Global Market for AI in Neurology, by End User, Through 2030
Table 31 : Global Market for Hospitals and Clinics for AI in Neurology, by Region, Through 2030
Table 32 : Global Market for Diagnostics Centers for AI in Neurology, by Region, Through 2030
Table 33 : Global Market for Research and Development Centers for AI in Neurology, by Region, Through 2030
Table 34 : Global Market for AI in Neurology, by Region, Through 2030
Table 35 : North American Market for AI in Neurology, by Product Type, Through 2030
Table 36 : North American Market for AI in Neurology, by Application, Through 2030
Table 37 : North American Market for AI in Neurology, by Technology, Through 2030
Table 38 : North American Market for AI in Neurology, by End User, Through 2030
Table 39 : North American Market for AI in Neurology, by Country, Through 2030
Table 40 : European Market for AI in Neurology, by Product Type, Through 2030
Table 41 : European Market for AI in Neurology, by Application, Through 2030
Table 42 : European Market for AI in Neurology, by Technology, Through 2030
Table 43 : European Market for AI in Neurology, by End User, Through 2030
Table 44 : European Market for AI in Neurology, by Country, Through 2030
Table 45 : Asia-Pacific Market for AI in Neurology, by Product Type, Through 2030
Table 46 : Asia-Pacific Market for AI in Neurology, by Application, Through 2030
Table 47 : Asia-Pacific Market for AI in Neurology, by Technology, Through 2030
Table 48 : Asia-Pacific Market for AI in Neurology, by End User, Through 2030
Table 49 : Asia-Pacific Market for AI in Neurology, by Country, Through 2030
Table 50 : South American Market for AI in Neurology, by Product Type, Through 2030
Table 51 : South American Market for AI in Neurology, by Application, Through 2030
Table 52 : South American Market for AI in Neurology, by Technology, Through 2030
Table 53 : South American Market for AI in Neurology, by End User, Through 2030
Table 54 : MEA Market for AI in Neurology, by Product Type, Through 2030
Table 55 : MEA Market for AI in Neurology, by Application, Through 2030
Table 56 : MEA Market for AI in Neurology, by Technology, Through 2030
Table 57 : MEA Market for AI in Neurology, by End User, Through 2030
Table 58 : Top 5 Leading Manufacturers of AI in Neurology Market, 2024
Table 59 : Collaborations and Partnerships: AI in Neurology Market, 2023–2025
Table 60 : Acquisition: AI in Neurology Market, 2024 and 2025
Table 61 : Business Expansion Activities of AI in Neurology Market, 2022–2025
Table 62 : Product Launches and FDA Approval Activities of AI in Neurology Market, 2022–2025
Table 63 : AI Ethics Principles
Table 64 : ESG Issues Related to Different AI Applications, 2024
Table 65 : ESG Highlights, by Major Players, 2023
Table 66 : ESG Rankings of Major AI in Neurology Products Manufacturing Companies, 2024
Table 67 : Information Sources for Compiling this Report
Table 68 : Abbreviations Used in the Report
Table 69 : Activ Surgical: Company Snapshot
Table 70 : Activ Surgical: Product Portfolio
Table 71 : Activ Surgical: News/Key Developments, 2022-2024
Table 72 : AIRAmed GmbH: Company Snapshot
Table 73 : AIRAmed GmbH: Product Portfolio
Table 74 : AIRAmed GmbH: News/Key Developments, 2023 and 2024
Table 75 : Brainomix: Company Snapshot
Table 76 : Brainomix: Product Portfolio
Table 77 : Brainomix: News/Key Developments, 2023-2025
Table 78 : BrainQ Technologies Ltd.: Company Snapshot
Table 79 : BrainQ Technologies Ltd.: Product Portfolio
Table 80 : BrainQ Technologies Ltd.: News/Key Developments, 2024 and 2025
Table 81 : Canon Inc.: Company Snapshot
Table 82 : Canon Inc.: Financial Performance, FY 2023 and 2024
Table 83 : Canon Inc.: Product Portfolio
Table 84 : Canon Inc.: News/Key Developments, 2023 and 2024
Table 85 : GE HealthCare: Company Snapshot
Table 86 : GE HealthCare: Financial Performance, FY 2023 and 2024
Table 87 : GE HealthCare: Product Portfolio
Table 88 : GE HealthCare: News/Key Developments, 2024 and 2025
Table 89 : Koninklijke Philips N.V.: Company Snapshot
Table 90 : Koninklijke Philips N.V.: Financial Performance, FY 2023 and 2024
Table 91 : Koninklijke Philips N.V.: Product Portfolio
Table 92 : Koninklijke Philips N.V.: News/Key Developments, 2023–2025
Table 93 : Medtronic: Company Snapshot
Table 94 : Medtronic: Financial Performance, FY 2023 and 2024
Table 95 : Medtronic: Product Portfolio
Table 96 : Medtronic: News/Key Developments, 2023-2025
Table 97 : Neosoma Inc.: Company Snapshot
Table 98 : Neosoma Inc.: Product Portfolio
Table 99 : Neosoma Inc.: News/Key Developments, 2022 and 2023
Table 100 : Neuralink: Company Snapshot
Table 101 : Neuralink: Product Portfolio
Table 102 : Neuralink: News/Key Developments, 2023-2025
Table 103 : NeuroX: Company Snapshot
Table 104 : NeuroX: Product Portfolio
Table 105 : NeuroX: News/Key Developments, 2022-2025
Table 106 : NVIDIA Corp.: Company Snapshot
Table 107 : NVIDIA Corp.: Financial Performance, FY 2023 and 2024
Table 108 : NVIDIA Corp.: Product Portfolio
Table 109 : NVIDIA Corp.: News/Key Development, 2025
Table 110 : Qure.ai: Company Snapshot
Table 111 : Qure.ai: Product Portfolio
Table 112 : Qure.ai: News/Key Developments, 2024 and 2025
Table 113 : Siemens Healthineers AG: Company Snapshot
Table 114 : Siemens Healthineers AG: Financial Performance, FY 2023 and 2024
Table 115 : Siemens Healthineers AG: Product Portfolio
Table 116 : Siemens Healthineers AG: Key Developments, 2023-2025
Table 117 : VIZ.ai Inc.: Company Snapshot
Table 118 : VIZ.ai Inc.: Product Portfolio
Table 119 : VIZ.ai Inc.: News/Key Developments, 2023-2025
Table 120 : List of a Few Emerging Startups/ Market Disruptors

List of Figures

List of Figures
Summary Figure : Global Market Shares of AI in Neurology, by Region, 2024
Figure 1 : Market Dynamics of AI in Neurology
Figure 2 : Number of Patents on AI in Neurology Documented Over Time, 2021–July 2025
Figure 3 : Shares of Patents on AI in Neurology, by Jurisdiction, 2021–2025
Figure 4 : Global Market Shares of AI in Neurology, by Product Type, 2024
Figure 5 : Global Market Shares of AI in Neurology, by Application, 2024
Figure 6 : Global Market Shares of AI in Neurology, by Technology, 2024
Figure 7 : Global Market Shares of AI in Neurology, by End User, 2024
Figure 8 : Global Market Shares of AI in Neurology, by Region, 2024
Figure 9 : Global Market Shares of AI in Neurology, by Leading Companies, 2024
Figure 10 : AI Can Be Used to MOP Things up in a Sustainability System
Figure 11 : Canon Inc.: Revenue Share, by Business Unit, FY 2024
Figure 12 : Canon Inc.: Revenue Share, by Country/Region, FY 2024
Figure 13 : GE HealthCare: Revenue Share, by Business Unit, FY 2024
Figure 14 : GE HealthCare: Revenue Share, by Country/Region, FY 2024
Figure 15 : Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2024
Figure 16 : Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2024
Figure 17 : Medtronic: Revenue Share, by Business Unit, FY 2024
Figure 18 : Medtronic: Revenue Share, by Country/Region, FY 2024
Figure 19 : NVIDIA Corp.: Revenue Share, by Business Unit, FY 2024
Figure 20 : NVIDIA Corp.: Revenue Share, by Country/Region, FY 2024
Figure 21 : Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2024
Figure 22 : Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2024

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧